Acquired haemophilia A (AHA) is a rare bleeding disorder caused by inhibitory
autoantibodies against coagulation factor VIII (FVIII). AHA is a disease that most commonly …

ABSTRACT Introduction Acquired hemophilia A (AHA) is a rare hemorrhagic autoimmune
disorder characterized by autoantibodies against coagulation factor VIII (FVIII). In …

Acquired hemophilia A (AHA) is a rare hemorrhagic coagulopathy caused by the presence
of autoantibodies that inhibit the activity of factor VIII (FVIII). Its diagnosis requires a high …

系统性红斑狼疮(systemic lupus erythematosus， SLE) 合并获得性血友病A (acquired
hemophilia A， AHA) 罕见， 容易延误诊断， 且病死率高， 有必要进一步加深对该疾病的认识 …

Acquired hemophilia A (AHA) is a rare autoimmune bleeding disorder which can be life-
threatening. AHA is due to autoantibodies against coagulation factor VIII. Disease onset may …

Introduction Immunosuppressive therapy (IST) for acquired hemophilia A (AHA) results in
remission within days to months in 60% to 80% of patients. However, little is known …

Hemophilia type A (HA) is the most common type of blood coagulation disorder. While the
vast majority of cases are inherited and caused by mutations in the F8 gene, recent data …

Saudi expert consensus on acquired hemophilia A diagnosis and management - ScienceDirect
Skip to main contentSkip to article Elsevier logo Journals & Books Help Search My account …

Abstract Background Acquired Haemophilia A (AHA) patients show a high response rate to
immunosuppressive therapy (IST) but few information about predictors of response and …

Аннотация Введение. Приобретенная гемофилия—редкое аутоиммунное
заболевание, характеризующееся появлением ингибитора фактора свертывания VIII …